October 27th, 2023
A big thank you to all our clients who attended our booth and our splendid CPHI event at the Picasso/Miro event. The splendid art is an inspiration to all those who appreciate creativity. So it is with our brand Amideus and its focus on phosphoramidites.
You cannot simply think today that one region can supply all the necessary ingredients to make successful pharma. This is why our ‘best of both worlds’ facilities match the strengths of two cultures to produce incredible chemistry of their own.
When we return to our various locations around the world from wonderful Barcelona we will be tired but inspired by the joy of life.
Thanks to all who made our trip productive and memorable in equal measure.
CEO and Member of the Board at Primopus
July 13th, 2023
Driven by a strong geo-political de-risking of overly dependent supply chain arrangements, a drastic rethinking about searching for and developing alternative options is underway in the pharma industry. This is evidenced by several leading companies defining new policies and the separation of activities from select countries.
Primopus has been working diligently to repurpose the pharma Intermediate and API facility it acquired in Switzerland and lays heavy emphasis on sustainable solutions. Our utilities will be net zero carbon from 2028 onwards.
The backward integration to our parent company Deccan Fine Chemicals in India brings massive scale and a huge resource of scientists who have experience in safely scaling-up of complex molecules.
With the launch of our Amideus brand this year, a lot of focus continues to be put on developing, scaling up and supplying of Phosphoramidites (RSMs) to the Oligonucleotide modality which is rapidly gaining interest in the industry.
As the offering broadens with additional critical RSM’s and custom intermediates we are listening to more customers asking about a 2nd independent supply chain option for their strategic API’s. This trend is accelerating and the importance of our Swiss/Indian cultural blend is pivotal in our hybrid value proposition which ultimately improves the reliable supply of essential and complex medicines to global patients.
March 22nd, 2023
Primopus reaches its first milestone towards becoming one of the largest phosphoramidites manufacturers in the world with Amideus.
Marcel Velterop, Primopus CEO, says “the idea of producing bulk Phosporamidites emerged from a best-of-both-worlds strategy that combines our Swiss installed capacity of up to 250m3 with the massive capacity and broad chemistry base of our parent Deccan Fine Chemicals in India.”
January 13th, 2023
Primopus welcomes 7 new colleagues as part of its CDMO expansion plans in Switzerland and wishes everybody a happy, healthy 2023.
During 2023 we expect our team to double in size as we start-up our new pilot plant during Q1 and commercial plant by Q4.
December 9th, 2022
As we enter into this festive period, we would like to take this opportunity to wish all of our customers, friends and family all the best for 2023.
2022 has seen us rebrand as Primopus as we embark on the next chapter of the company. 2023 will be equally exciting as we continue to expand our capabilities with new state of the art equipment and look to bring more talent on board.
November 10th, 2022
Prof Katrin, Director of the Senckenberg Biodiversity and Climate Research Centre gave a very clear message on the importance of biodiversity in achieving a healthy world of the future. Pointing out the interconnectivity of climate, biodiversity and ecology it was clear that multiple species extinction was already happening for a lack of coordinated action worldwide.
Loss of biodiversity has already cost lives, the recent Tsunami in the Indian Ocean highlighted this. More lives were lost in areas where mangroves had been cut.
From a scientific perspective, we now know that the reduction in biodiversity loss can be halted by implementing certain initiatives.
Creating large protected areas of land and ocean including restoring ecosystems with the planting of trees and mangroves.
Changing the mix of agriculture, encouraging organic agriculture with more targeted use of fertiliser. We need to increase yield but understand more fully the knock-on effect of pesticides and if necessary reduce their usage.
A change in diet for northern countries to a more plant-based diet. Three-quarters of world crop production goes to feed animals. Reducing meat consumption would yield 160 x more land for vegetables which humans can eat directly.
Marcel Velterop CEO of Primopus confirmed that the money Primopus might have spent on a stand at the Frankfurt CPHI had gone into this event to promote a debate on biodiversity and also various initiatives at Deccan to plant trees, preserve wildlife and support renewable energy.
The global challenge of correcting global warming and stopping the extinction of numerous species transcended any corporate or P&L considerations.
Primopus, the newly named pharma CDMO combines an ambitious upcycled facility in Basel, Switzerland with the large intermediates provider Deccan in India.
Marcel confirmed that more improvement was needed by everybody in the industry. It was not so easy to upcycle the facility in Basel, but faced with using another greenfield site it was better for all to upgrade the Basel site rather than build on the greenbelt.
Primopus encourages everybody to embrace ‘exceptional life’ whether it be humans, flora or fauna. By using human ingenuity, we might yet correct some of the damage done to our climate and species biodiversity.
October 26th, 2022
Primopus is organising a VIP event during CPHI Frankfurt, focused on preserving biodiversity and ecosystems at the Senckenberg Museum in Frankfurt. (Watch our brief video presentation below.)
This event will be centred around a talk by Prof. Dr Katrin Bӧhning-Gaese, director of the Senckenberg Biodiversity and Climate Research Center. She won the German Environmental Award in 2021, the largest award for ecological and social commitment in Europe.
The need for the protection of all species on our planet, addressing climate change and embracing human life is an urgent call to action for all of us. We thank Prof. Böhning-Gaese and the Senckenberg for their efforts to promote biodiversity and see this as critically important in our everyday lives at home or in business.
Primopus is developing its CDMO capability in Basel on a site which is being reinvigorated and invested in. It is setting ambitious carbon reduction plans: net zero carbon utilities by 2028. Deccan Fine Chemicals have implemented a wealth of initiatives from tree planting to wildlife habitat preservation.
We have created this brief video presentation that outlines these various initiatives to date and yet there is much more to do. We hope this example will inspire others to follow suit, just as we are inspired by those calling for more positive initiatives. ‘Embracing Exceptional Life’ means we have to value all life on our planet to preserve it for future generations.
October 20th, 2022
Primopus declares its goal of reaching net zero by working closely with its partner Getec Park.Swiss by 2028.
In line with our new promise and purpose to ‘embrace exceptional life’, we are on the right path to source all our utilities and energy supply to make our production of RSM’s, GMP intermediates and API’s fully net zero.
In phase 2 we will strive to meet the global climate goals and reach net zero for the integrated supply chain latest by 2050.
September 8th, 2022
The Deccan business brings with it a great heritage of sustainability, backward integration into fine-chemical building blocks and large-scale capacity across its multiple sites. Major investments are being made to further enhance the Primopus offering across both sites in Bael, Switzerland and Goa, India
This investment gives Primopus, the ability to secure critical custom-building blocks required for all phases of NCE development we perform for our customers, especially for launch and commercial supply.